which glp 1 is oral GLP-1s rapidly expanding user base Oral GLP-1s rapidly expanding user
Description
Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option

CBS News medical correspondent Dr

This review outlines the physiological role of amylin and highlights recent clinical studies exploring its therapeutic potential in diabetes and obesity
Archives of physiology and biochemistry, 130(6), 678685

Source: Novo Nordisk - PR Newswire
